A new study from Italy showed that using statins while on Xtandi would help extend life longer than without using the statins. The study compared the use of statins in men taking Xtandi and men taking Zytiga. While statins helped men who were taking Xtandi, taking statins was of no help to men taking Zytiga. [...]
A breast cancer test may be adapted to help men with advanced stage prostate cancer know – in advance - if androgen deprivation therapy (ADT) will help them. Researchers from UCSF and the University of Michigan investigated genetic subtypes of prostate cancer, to see what the difference could predict. The researchers divided prostate tumors into [...]
As we get ready for next weeks' American Society of Clinical Oncology annual meeting, I thought advanced prostate cancer patients would find it helpful to see this thirty minute review from last years meeting. Click >>> https://www.patientpower.info/video/asco-advanced-prostate-cancer-roundtable-discussion http://malecare.org/the-development-of-a-novel-blood-biomarker-for-detecting-ar-v7-and-resistance-to-zytiga-and-xtandi/
Androgen deprivation therapy (ADT) is a first line treatment for men when prostate cancer has spread beyond the prostate. Men die from prostate cancer after their disease becomes castration resistant prostate cancer (CRPC). Anti-androgen treatments such as Enzalutamide (Xtandi) have lengthened the life of thousands of advanced prostate cancer men around the world. Ultimately, even [...]
You may live longer if you feel good about life while taking radium-223 (Xofigo). Dr Neal Shore from the Carolina Urologic Research Center studied how health related quality of life (HRQoL) might be related to overall survival while being treated for advanced prostate cancer with Xofigo. Approximately 800 men with advanced prostate cancer were asked [...]